Intellectual Property India Publishes Patent Application for 'Methods And Compositions For Prognosis And Treatment Of Dilated Cardiomyopathy And Heart Failure' Filed by The General Hospital Corporation; The United States Government As Represented By The Department Of Veterans Affairs; and The Broad Institute Inc.

MUMBAI, India, June 20 -- Intellectual Property India has published a patent application (202517021433 A) filed by The General Hospital Corporation; The United States Government As Represented By The Department Of Veterans Affairs; and The Broad Institute Inc., Boston, on March 10, for 'methods and compositions for prognosis and treatment of dilated cardiomyopathy and heart failure.'

Inventor(s) include Aragam Krishna; Huffman Jennifer; and Gaziano Liam.

The application for the patent was published on June 20, under issue no. 25/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are methods and compositions for the diagnosis prognosis and treatment of dilated cardiomyopathy (DCM) and heart failure (HF). In particular provided are methods and compositions for detecting a loss of function mutation in the CD36 gene. Provided are methods of determining the likelihood that a subject will respond to a treatment for DCM or HF based on the identification of a CD36 mutation in a sample from the subject."

The patent application was internationally filed on Aug. 25, 2023, under International application No.PCT/US2023/031136.

Disclaimer: Curated by HT Syndication.